NetworkNewsBreaks – Supreme Cannabis Company Inc
Post# of 316
(Total Views: 308)
Posted On: 03/18/2019 3:17:59 PM
NetworkNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Continues to Achieve High Revenues within Booming Cannabis Industry
Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recently reported its financial and operational results for the period ended December 31, 2018. The report highlights the company’s capability to maintain high revenues within the cannabis industry. An article discussing SPRWF reads, “The Q2 report also detailed Supreme Cannabis’ profitability. The company recorded a 359-percent increase in revenue from Q2 2018 ($1.68 million) to Q2 2019 ($7.72 million). The company has also been making moves to stay competitive within the cannabis oil products market, an industry that has been dubbed the next ‘gold rush’ since the 2018 United States Farm Bill removed hemp from the list of controlled substances (http://nnw.fm/v8oJT). Demand for hemp-derived CBD products continues to grow worldwide and is estimated to become a $22-billion industry by 2022. Staying ahead of the curve, Supreme Cannabis contracted Medipharm Labs Co. to help coordinate the launch of the company’s cannabis oil product line.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recently reported its financial and operational results for the period ended December 31, 2018. The report highlights the company’s capability to maintain high revenues within the cannabis industry. An article discussing SPRWF reads, “The Q2 report also detailed Supreme Cannabis’ profitability. The company recorded a 359-percent increase in revenue from Q2 2018 ($1.68 million) to Q2 2019 ($7.72 million). The company has also been making moves to stay competitive within the cannabis oil products market, an industry that has been dubbed the next ‘gold rush’ since the 2018 United States Farm Bill removed hemp from the list of controlled substances (http://nnw.fm/v8oJT). Demand for hemp-derived CBD products continues to grow worldwide and is estimated to become a $22-billion industry by 2022. Staying ahead of the curve, Supreme Cannabis contracted Medipharm Labs Co. to help coordinate the launch of the company’s cannabis oil product line.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Supreme Pharmaceuticals (SPRWF) Stock Research Links
Scroll down for more posts ▼